AAAAAA

   
Results: 1-3 |
Results: 3
X-ray mapping in heterocyclic design: III. Diffractometric study of the crystal structure of 1-methyl-2-oxo-2,3-dihydroimidazo[1,2-a]pyridinium bromide
Authors: Rybakov, VB Zhukov, SG Babaev, EV Mazina, OS Aslanov, LA
Citation: Vb. Rybakov et al., X-ray mapping in heterocyclic design: III. Diffractometric study of the crystal structure of 1-methyl-2-oxo-2,3-dihydroimidazo[1,2-a]pyridinium bromide, CRYSTALLO R, 45(2), 2000, pp. 261-263
X-ray mapping in heterocyclic design: II. Diffractometric study of crystalline 2-oxo-2,3-dihydroimidazo[1,2-a]pyridine hydrochloride
Authors: Rybakov, VB Zhukov, SG Babaev, EV Mazina, OS Aslanov, LA
Citation: Vb. Rybakov et al., X-ray mapping in heterocyclic design: II. Diffractometric study of crystalline 2-oxo-2,3-dihydroimidazo[1,2-a]pyridine hydrochloride, CRYSTALLO R, 45(1), 2000, pp. 103-104
X-ray mapping in heterocyclic design. I. Diffractometric study of crystalline 1,2-dihydro-2-imino-1-carboxymethylpyridine monohydrate: Structural evidence for the zwitterionic character of the molecule
Authors: Rybakov, VB Zhukov, SG Babaev, EV Mazina, OS Aslanov, LA
Citation: Vb. Rybakov et al., X-ray mapping in heterocyclic design. I. Diffractometric study of crystalline 1,2-dihydro-2-imino-1-carboxymethylpyridine monohydrate: Structural evidence for the zwitterionic character of the molecule, CRYSTALLO R, 44(6), 1999, pp. 997-999
Risultati: 1-3 |